MedTrace Logo

Restenosis Intrastent: Treatment of Bioresorbable Vascular Scaffolds Restenosis

NCT03167424 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2017-08-11

No results posted yet for this study

Summary

The treatment of patients with intra-stent restenosis (ISR) of Bioresorbable Vascular Scaffolds (Abbott Vascular) remains a challenge. This study will assess the incidence, predisposing factors, pathophysiology and prognosis of the patient in this setting.

Conditions

  • Coronary In-stnent Restenosis

Interventions

DEVICE

Treatment of restenosis

Treatment of in-stent restenosis

Sponsors & Collaborators

  • Fundación de Investigación Biomédica - Hospital Universitario de La Princesa

    collaborator OTHER

  • Instituto de Investigación Sanitaria Hospital Universitario de la Princesa

    collaborator OTHER

  • Abbott Medical Devices

    collaborator INDUSTRY

  • Spanish Society of Cardiology

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2017-12-31
Completion
2021-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03167424 on ClinicalTrials.gov